文献速递中医内科中药与中成药合理使用

愈痔止血颗粒经JAK/STAT通路调控溃疡性结肠炎小鼠结肠T细胞分化

Yuzhi Zhixue Granules regulate the JAK/STAT pathway to affect T-cell differentiation in the colon of ulcerative colitis.
PubMed 文献 · Phytomedicine · 2025-08-29

本研究探讨愈痔止血颗粒(YZZX)对DSS诱导小鼠溃疡性结肠炎的治疗潜力及免疫调节机制。YZZX可减轻体重下降、降低DAI评分、改善组织病理损伤并阻止结肠缩短,同时上调MUC-2及紧密连接蛋白表达。转录组分析表明YZZX主要通过抑制JAK/STAT信号通路,重新平衡Th1/Th2与Th17/Treg细胞反应,从而缓解黏膜炎症。

要点

  • YZZX可改善DSS诱导UC小鼠的疾病活动度和结肠病理损伤。
  • YZZX通过抑制JAK/STAT通路调节Th1/Th2与Th17/Treg平衡。
  • YZZX中的小分子化合物与碳点纳米组分具有协同保护效应。

核心结论

  • YZZX颗粒主要通过抑制JAK/STAT信号通路,重新平衡结肠Th1/Th2和Th17/Treg细胞群,从而发挥免疫调节作用并减轻黏膜炎症。
  • 本研究首次系统证明传统中药配方中的小分子化合物与碳点纳米组分在DSS诱导UC小鼠模型中具有协同保护效应。

研究设计与样本

  • 采用UHPLC-QE-MS等现代分析技术鉴定YZZX中的主要小分子成分及大分子纳米组分(碳点)。
  • 小鼠通过自由饮用2.5% DSS溶液诱导UC,并口服给予YZZX。
  • 通过DAI评分、体重、结肠长度、溃疡面积及组织病理学评估抗炎效果,并对结肠组织进行转录组测序、流式细胞术、ELISA、RT-qPCR和Western blotting。

主要发现

  • YZZX显著减轻UC小鼠体重下降、降低DAI评分、改善组织病理损伤并阻止结肠缩短。
  • YZZX通过促进MUC-2及紧密连接蛋白(claudin、occludin、ZO-1)上调改善肠道屏障功能。
  • YZZX通过调节细胞因子分泌和转录因子表达,恢复Th17/Treg和Th1/Th2免疫平衡。
  • 转录组分析显示YZZX主要通过JAK/STAT信号通路调节结肠炎免疫炎症反应,Western blotting和RT-qPCR证实YZZX下调磷酸化JAK/STAT蛋白表达抑制该通路激活。

临床怎么用

  • YZZX颗粒在DSS诱导小鼠UC模型中显示出免疫调节和黏膜保护作用,提示其可能作为UC的潜在治疗选择。
  • 其作用机制涉及抑制JAK/STAT通路及调节T细胞分化,为后续临床转化研究提供实验依据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Yuzhi Zhixue (YZZX) granules, a classic Chinese herbal remedy, have demonstrated efficacy in managing hemorrhagic and inflammatory conditions, and are clinically used to treat uterine bleeding. Building upon their documented clinical applications and phytochemical composition, we hypothesized that YZZX may also possess therapeutic potential against ulcerative colitis (UC). This research aimed to examine the immunomodulatory effects of YZZX granules on Th1/Th17-mediated immune reactions in a murine UC model induced by dextran sulfate sodium (DSS). METHODS: The major small-molecule constituents and macromolecular nano-components, specifically carbon dots (CDs), in YZZX were identified using UHPLC-QE-MS and other modern analytical techniques. UC was induced in mice via ad libitum access to a 2.5 % DSS solution, with YZZX administered orally. Anti-inflammatory effects were assessed by monitoring disease activity index (DAI) scores, body weight, colon length, ulcer area, and histopathological features. To uncover the mechanistic pathways of YZZX in UC treatment, transcriptomic sequencing, Flow cytometry, ELISA, RT-qPCR and Western blotting were conducted on colon tissue samples. RESULTS: YZZX significantly mitigated body weight loss, reduced DAI scores, ameliorated histopathological damage, and prevented colon shortening in UC mice. It improved the intestinal barrier function by promoting the upregulation of mucin MUC-2 and tight junction proteins (e.g., claudin, occludin, and ZO-1). Additionally, YZZX restored immune balance by modulating Th17/Treg and Th1/Th2 cell responses through the normalization of cytokine secretion and transcription factor expression. Transcriptomic analysis revealed that YZZX modulates the immune-inflammatory responses in colitis primarily via the JAK/STAT signaling pathway. These findings were further validated by Western blotting and RT-qPCR, which showed that YZZX suppressed the activation of this pathway by downregulating phosphorylated JAK/STAT protein expression. CONCLUSION: YZZX granules exert immunomodulatory effects primarily by rebalancing Th1/Th2 and Th17/Treg cell populations in the colon via inhibition of the JAK/STAT signaling pathway, thereby alleviating mucosal inflammation. This is the first study to systematically demonstrate the synergistic protective effects of both small-molecule compounds and carbon dot nano-components, derived from a traditional Chinese medicine formula in a DSS-induced murine model of UC.

来源:Phytomedicine,查看原文。版权归原作者所有。

引用

  1. Zhang Y, He C, Zhao Y, et al. Yuzhi Zhixue Granules regulate the JAK/STAT pathway to affect T-cell differentiation in the colon of ulcerative colitis. Phytomedicine. 2025. PMID: 40907405. doi:10.1016/j.phymed.2025.157198

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。